Bright Minds Biosciences (DRUG) Research & Development: 2020-2021
Historic Research & Development for Bright Minds Biosciences (DRUG) over the last 1 years, with Sep 2021 value amounting to $1.8 million.
- Bright Minds Biosciences' Research & Development rose 2182.24% to $1.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2021, which is 4063.09% up from last year.
- Latest data reveals that Bright Minds Biosciences reported Research & Development of $1.8 million as of Q3 2021, which was up 1,028.66% from $155,418 recorded in Q2 2021.
- Bright Minds Biosciences' Research & Development's 5-year high stood at $1.8 million during Q3 2021, with a 5-year trough of $76,861 in Q3 2020.
- Its 2-year average for Research & Development is $616,527, with a median of $270,611 in 2020.
- Data for Bright Minds Biosciences' Research & Development shows a peak YoY soared of 2,182.24% (in 2021) over the last 5 years.
- Quarterly analysis of 2 years shows Bright Minds Biosciences' Research & Development stood at $270,611 in 2020, then surged by 2,182.24% to $1.8 million in 2021.
- Its Research & Development was $1.8 million in Q3 2021, compared to $155,418 in Q2 2021 and $825,600 in Q1 2021.